223 related articles for article (PubMed ID: 24517854)
1. Different mechanisms of homologous and heterologous μ-opioid receptor phosphorylation.
Mann A; Illing S; Miess E; Schulz S
Br J Pharmacol; 2015 Jan; 172(2):311-6. PubMed ID: 24517854
[TBL] [Abstract][Full Text] [Related]
2. Heterologous regulation of agonist-independent μ-opioid receptor phosphorylation by protein kinase C.
Illing S; Mann A; Schulz S
Br J Pharmacol; 2014 Mar; 171(5):1330-40. PubMed ID: 24308893
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of opioid drug effects by hierarchical multi-site phosphorylation.
Just S; Illing S; Trester-Zedlitz M; Lau EK; Kotowski SJ; Miess E; Mann A; Doll C; Trinidad JC; Burlingame AL; von Zastrow M; Schulz S
Mol Pharmacol; 2013 Mar; 83(3):633-9. PubMed ID: 23239825
[TBL] [Abstract][Full Text] [Related]
4. Multisite phosphorylation is required for sustained interaction with GRKs and arrestins during rapid μ-opioid receptor desensitization.
Miess E; Gondin AB; Yousuf A; Steinborn R; Mösslein N; Yang Y; Göldner M; Ruland JG; Bünemann M; Krasel C; Christie MJ; Halls ML; Schulz S; Canals M
Sci Signal; 2018 Jul; 11(539):. PubMed ID: 30018083
[TBL] [Abstract][Full Text] [Related]
5. Deciphering µ-opioid receptor phosphorylation and dephosphorylation in HEK293 cells.
Doll C; Pöll F; Peuker K; Loktev A; Glück L; Schulz S
Br J Pharmacol; 2012 Nov; 167(6):1259-70. PubMed ID: 22725608
[TBL] [Abstract][Full Text] [Related]
6. Analgesic tolerance to high-efficacy agonists but not to morphine is diminished in phosphorylation-deficient S375A μ-opioid receptor knock-in mice.
Grecksch G; Just S; Pierstorff C; Imhof AK; Glück L; Doll C; Lupp A; Becker A; Koch T; Stumm R; Höllt V; Schulz S
J Neurosci; 2011 Sep; 31(39):13890-6. PubMed ID: 21957251
[TBL] [Abstract][Full Text] [Related]
7. A novel G protein-biased agonist at the μ opioid receptor induces substantial receptor desensitisation through G protein-coupled receptor kinase.
Groom S; Blum NK; Conibear AE; Disney A; Hill R; Husbands SM; Li Y; Toll L; Kliewer A; Schulz S; Henderson G; Kelly E; Bailey CP
Br J Pharmacol; 2023 Apr; 180(7):943-957. PubMed ID: 33245558
[TBL] [Abstract][Full Text] [Related]
8. Agonist-selective patterns of µ-opioid receptor phosphorylation revealed by phosphosite-specific antibodies.
Doll C; Konietzko J; Pöll F; Koch T; Höllt V; Schulz S
Br J Pharmacol; 2011 Sep; 164(2):298-307. PubMed ID: 21449911
[TBL] [Abstract][Full Text] [Related]
9. Loss of morphine reward and dependence in mice lacking G protein-coupled receptor kinase 5.
Glück L; Loktev A; Moulédous L; Mollereau C; Law PY; Schulz S
Biol Psychiatry; 2014 Nov; 76(10):767-74. PubMed ID: 24629717
[TBL] [Abstract][Full Text] [Related]
10. Heteromers of μ-δ opioid receptors: new pharmacology and novel therapeutic possibilities.
Fujita W; Gomes I; Devi LA
Br J Pharmacol; 2015 Jan; 172(2):375-87. PubMed ID: 24571499
[TBL] [Abstract][Full Text] [Related]
11. Positive allosteric modulators of the μ-opioid receptor: a novel approach for future pain medications.
Burford NT; Traynor JR; Alt A
Br J Pharmacol; 2015 Jan; 172(2):277-86. PubMed ID: 24460691
[TBL] [Abstract][Full Text] [Related]
12. Novel GPCR paradigms at the μ-opioid receptor.
Thompson GL; Kelly E; Christopoulos A; Canals M
Br J Pharmacol; 2015 Jan; 172(2):287-96. PubMed ID: 24460711
[TBL] [Abstract][Full Text] [Related]
13. Change in functional selectivity of morphine with the development of antinociceptive tolerance.
Macey TA; Bobeck EN; Suchland KL; Morgan MM; Ingram SL
Br J Pharmacol; 2015 Jan; 172(2):549-61. PubMed ID: 24666417
[TBL] [Abstract][Full Text] [Related]
14. Morphine-induced internalization of the L83I mutant of the rat μ-opioid receptor.
Cooke AE; Oldfield S; Krasel C; Mundell SJ; Henderson G; Kelly E
Br J Pharmacol; 2015 Jan; 172(2):593-605. PubMed ID: 24697554
[TBL] [Abstract][Full Text] [Related]
15. Cellular signalling of non-synonymous single-nucleotide polymorphisms of the human μ-opioid receptor (OPRM1).
Knapman A; Connor M
Br J Pharmacol; 2015 Jan; 172(2):349-63. PubMed ID: 24527749
[TBL] [Abstract][Full Text] [Related]
16. Involvement of PKC alpha and G-protein-coupled receptor kinase 2 in agonist-selective desensitization of mu-opioid receptors in mature brain neurons.
Bailey CP; Oldfield S; Llorente J; Caunt CJ; Teschemacher AG; Roberts L; McArdle CA; Smith FL; Dewey WL; Kelly E; Henderson G
Br J Pharmacol; 2009 Sep; 158(1):157-64. PubMed ID: 19309357
[TBL] [Abstract][Full Text] [Related]
17. Phosphoproteomic analysis of the mouse brain mu-opioid (MOP) receptor.
Moulédous L; Froment C; Burlet-Schiltz O; Schulz S; Mollereau C
FEBS Lett; 2015 Aug; 589(18):2401-8. PubMed ID: 26226422
[TBL] [Abstract][Full Text] [Related]
18. Role of protein kinase C (PKC) in agonist-induced mu-opioid receptor down-regulation: II. Activation and involvement of the alpha, epsilon, and zeta isoforms of PKC.
Kramer HK; Simon EJ
J Neurochem; 1999 Feb; 72(2):594-604. PubMed ID: 9930731
[TBL] [Abstract][Full Text] [Related]
19. Does PKC activation increase the homologous desensitization of μ opioid receptors?
Arttamangkul S; Birdsong W; Williams JT
Br J Pharmacol; 2015 Jan; 172(2):583-92. PubMed ID: 24697621
[TBL] [Abstract][Full Text] [Related]
20. Role for G protein-coupled receptor kinase in agonist-specific regulation of mu-opioid receptor responsiveness.
Zhang J; Ferguson SS; Barak LS; Bodduluri SR; Laporte SA; Law PY; Caron MG
Proc Natl Acad Sci U S A; 1998 Jun; 95(12):7157-62. PubMed ID: 9618555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
